The importance of biological rhythms in drug treatment of hypertension and sex-dependent modifications

References

• Halberg F, Halberg E, Barnum CP, Bittner JJ. Physiologic 24-hour periodicity in human beings and mice, the lighting regimen and daily routine. Am Assoc Adv Sci Pub. 1951;55:803.
   Google Scholar
• Halberg F. Some physiological and clinical aspects of 24-hour periodicity. Lancet. 1953;73(1):20–32.
   Google Scholar
• Santorio S. De Statica Medicina Sectionibus Aphorismorum Septem Comprehensa. Venice: Nicolaum Polum; 1614.
   Google Scholar
• Hall JC. Molecular neurogenetics of biological rhythms. J Neurogenet. 1998;12(3):115–181.
   Web of Science ®Google Scholar
• Takahashi J. Circadian clock genes are ticking (perspective). Science. 1992;258(5080):238–240.
   Web of Science ®Google Scholar
• Hastings M. The brain, circadian rhythms, and clock genes. BMJ. 1998;317(7174):1704–1707.
   Google Scholar
• Aschoff J, Wever R. Human circadian rhythms: a multioscillatory system. Fed Proc. 1976;35(12):2326–2332.
   Google Scholar
• Ebihara S, Tsuji K, Kondo K. Strain differences of the mouse’s free- running circadian rhythm in continuous darkness. Physiol Behav. 1978;20:795–799.
   PubMed Web of Science ®Google Scholar
• Konopka RJ, Benzer S. Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci U SA. 1971;68(9):2112–2116.
   PubMed Web of Science ®Google Scholar
• Kyriacou CP, Hall JC. Circadian rhythm mutations in Drosophila melanogaster affect short-term fluctuations in the male’s courtship song. Proc Natl Acad Sci U S A. 1980;77(11):6729–6733.
   PubMed Web of Science ®Google Scholar
• Hastings MH. The Vertebrate Clock: Localisation, Connection and Entrainment. Heidelberg: Springer; 1997;125:1–28.
   Google Scholar
• Reppert SM. Cellular and molecular basis of circadian timing in mammals. Semin Perinatol. 2000;24(4):243–246.
   Web of Science ®Google Scholar
• Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647–676.
   PubMed Web of Science ®Google Scholar
• Schibler U. Circadian rhythms. New cogwheels in the clockworks. Nature. 1998;393:620–621.
   PubMed Web of Science ®Google Scholar
• Harms E, Kivimae S, Young MW, Saez L. Posttranscriptional and posttranslational regulation of clock genes. J Biol Rhythms. 2004;19(5):361–373.
   Web of Science ®Google Scholar
• Hardin PE. Transcription regulation within the circadian clock: the E-box and beyond. J Biol Rhythms. 2004;19(5):348–360.
   Web of Science ®Google Scholar
• Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet. 2004;5:407–441.
   PubMed Web of Science ®Google Scholar
• Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell cycle phases. Am J Pathol. 2001;158(5):1793–1801.
   PubMed Web of Science ®Google Scholar
• Storch KF, Lipan O, Leykin I, et al. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002;417(6884):78–83.
   PubMed Web of Science ®Google Scholar
• Schibler U. The daily timing of gene expression and physiology in mammals. Dialogues Clin Neurosci. 2007;9(3):257–272.
   PubMedGoogle Scholar
• Aschoff J. Zeitgeber der tierischen Tagesperiodik. Naturwissenschaften. 1954;41(3):49–56.
   Google Scholar
• Aschoff J. Circadian Clocks. Amsterdam, The Netherlands: North Holland; 1965.
   Google Scholar
• Aschoff J, Pöhl H. Phase relations between a circadian rhythm and its Zeitgeber within the range of entrainment. Naturwissenschaften. 1978;65:80–84.
   PubMed Web of Science ®Google Scholar
• Witte K, Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive Sprague-Dawley rats. J Interdiscpl Cycle Res. 1993;24:328–334.
   Web of Science ®Google Scholar
• Witte K, Lemmer B. Free-running rhythms in blood pressure and heart rate in normotensive and transgenic hypertensive rats. Chronobiol Int. 1995;12(4):237–247.
   Web of Science ®Google Scholar
• Witte K, Schnecko A, Buijs RM, et al. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats. Chronobiol Int. 1998;15(2):135–145.
   Web of Science ®Google Scholar
• Curtis AM, Cheng Y, Kapoor S, Reilly D, Price TS, Fitzgerald GA. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci U S A. 2007;104(9):3450–3455.
   PubMed Web of Science ®Google Scholar
• Kräuchi K, Wirz-Justice A. Circadian rhythm of heat production, heart rate, and skin and core temperature under unmasking conditions in men. Am J Physiol. 1994;267:R819–R829.
   PubMed Web of Science ®Google Scholar
• Kerkhof GA, Van Dongen HP, Bobbert AC. Absence of endogenous circadian rhythmicity in blood pressure? Am J Hypertens. 1998;11(3 Pt 1):373–377.
   PubMed Web of Science ®Google Scholar
• Van Dongen HP, Maislin G, Kerkhof GA. Repeated assessment of the endogenous 24-hour profile of blood pressure under constant routine. Chronobiol Int. 2001;18(1):85–98.
   PubMed Web of Science ®Google Scholar
• Shea SA, Hilton MF, Hu K, Scheer FA. Existence of an endogenous circadian blood pressure rhythm in humans that peaks in the evening. Circ Res. 2011;108(8):980–984.
   Web of Science ®Google Scholar
• Redfern P, Lemmer B, eds. Phys iology and Pharm acology of.B iological Rhythms. Vol 125. Berlin, Germany: Springer; 1997.
   Google Scholar
• Reinberg A, Smolensky MH. Biological Rhythms and Medicine. Heidelberg, Germany: Springer-Verlag; 1983.
   Google Scholar
• Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131–138.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Smolensky MH, et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int. 2005;22(3):417–453.
   PubMed Web of Science ®Google Scholar
• Waters DD, Miller DD, Bouchard A, Bosch X, Theroux P. Circadian variation in variant angina. Am J Cardiol. 1984;54:61–64.
   PubMed Web of Science ®Google Scholar
• Hartig V, Lemmer B. Gender-related circadian variations in blood pressure, plasma catecholamines and urinary excretion of nitric oxide and cGMP. Naunyn Schmiedebergs Arch Pharmacol. 2003;367 Suppl 1:R113.
   Google Scholar
• Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmacol Ther. 2006;111(3):629–651.
   PubMed Web of Science ®Google Scholar
• Zuther P, Gorbey S, Lemmer B. Chronos-Fit revised Version 1.06. http://www.ma.uni-heidelberg.de/inst/phar/lehre/chrono.html. 2009.
   Google Scholar
• Patel MS, Elefteriou F. The new field of neuroskeletal biology. Calcif Tissue Int. 2007;80(5):337–347.
   Web of Science ®Google Scholar
• Pechere-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004;17(10):994–1001.
   Web of Science ®Google Scholar
• Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.
   PubMed Web of Science ®Google Scholar
• Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–390.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):447–452.
   PubMed Web of Science ®Google Scholar
• Andreotti F, Kluft C. Circadian variation of fibrinolytic activity in blood. Chronobiol Int. 1991;8(5):336–351.
   PubMed Web of Science ®Google Scholar
• Walters J, Skene D, Hampton SM, Ferns GA. Biological rhythms, endothelial health and cardiovascular disease. Med Sci Monit. 2003;9(1):RA1-RA8.
   Web of Science ®Google Scholar
• Westgate EJ, Cheng Y, Reilly DF, et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation. 2008;117(16):2087–2095.
   PubMed Web of Science ®Google Scholar
• Anea CB, Zhang M, Stepp DW, et al. Vascular disease in mice with a dysfunctional circadian clock. Circulation. 2009;119(11):1510–1517.
   Web of Science ®Google Scholar
• Anea CB, Ali MI, Osmond JM, et al. Matrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice. Arterioscler Thromb Vasc Biol. 2010;30(12):2535–2543.
   PubMed Web of Science ®Google Scholar
• Bode-Böger SM, Boger RH, Kielstein JT, Loffler M, Schaffer J, Frolich JC. Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. J Investig Med. 2000;48(2):125–132.
   Web of Science ®Google Scholar
• Cugini P, Baldoni F, De Rosa R, et al. Higher blood pressure load (baric impact) in normotensives with endothelial dysfunction: a paraphysiological status of “pre-hypertension”. Clin Ter. 2002;153(5):309–315.
   PubMedGoogle Scholar
• Bruguerolle B, Lemmer B. Recent advances in chronopharmacokinetics: methodological problems. Life Sci. 1993;52:1809–1824.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Bruguerolle B. Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet. 1994;26(6):419–427.
   PubMed Web of Science ®Google Scholar
• Lemmer B. . Chronobiology and chronopharmacology of hypertension: importance of timing of dosing. In: White WB, editor. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. 2nd ed. Totowa, NJ: Humana Press; 2007:410–435.
   Google Scholar
• Reinberg A, Smolensky MH. Circadian changes of drug disposition in man. Clin Pharmacokinet. 1982;7:401^20.
   Web of Science ®Google Scholar
• Reinberg A. Chronopharmacology in Man. Stuttgart, Germany: Schattauer-Verlag; 1974.
   Google Scholar
• Lemmer B, editor. Chronopharmacology: Cellular and Biochemical Interactions. New York, NY: Marcel Dekker; 1989.
   Google Scholar
• Lemmer B, Portaluppi F. Chronopharmacology of cardiovascular diseases. In: Redfern PH, Lemmer B, editors. Physiology and Pharmacology of Biological Rhythms. Heidelberg, Germany: Springer-Verlag; 1997;125:251–297.
   Google Scholar
• Koukkari WL, Sothern RB. Introducing Biological Rhythms. New York, NY: Springer; 2006.
   Google Scholar
• Lemmer B. Chronopharmacokinetics. J Pharm Pharmacol. 1998;50 Suppl 3:3.
   Google Scholar
• Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93:515–518.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Nold G. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol. 1991;32:627–629.
   PubMed Web of Science ®Google Scholar
• Bruguerolle B, Bouvenot G, Bartolin R, Manolis J. Chronopharma- cocinetique de la digoxine chez le sujet de plus de soixante-dix ans. Therapie. 1988;43:251–253.
   PubMed Web of Science ®Google Scholar
• Witte K, Makabe T, Mattes A, Ganten D, Lemmer B. Circadian time-dependency of the dose-response effects of enalapril on 24-hour patterns in blood pressure and heart rate of spontaneously and transgenic hypertensive rats. Fundam Clin Pharmacol. 1993;7:387.
   Google Scholar
• Scheidel B, Lemmer B. Chronopharmacology of oral nitrates in healthy subjects. Chronobiol Int. 1991;8:409–419.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Behne S, Becker HJ. Chronopharmacology of oral nifedipine in healthy subjects. Eur J Clin Pharmacol. 1989; 36 Suppl:A177.
   Google Scholar
• Lemmer B, Scheidel B, Stenzhorn G, et al. Clinical chronopharmacol- ogy of oral nitrates. Z Kardiol. 1989;78 Suppl 2:61–63.
   Google Scholar
• Lemmer B, Scheidel B, Blume H, Becker HJ. Clinical chronopharma- cology of oral sustained-release isosorbide-5-mononitrate in healthy subjects. Eur J Clin Pharmacol. 1991;40:71–75.
   PubMed Web of Science ®Google Scholar
• Nold G, Lemmer B. Pharmacokinetics of sustained-release molsidomine after morning versus evening application in healthy subjects. Naunyn Schmiedebergs Arch Pharmacol. 1998;357 Suppl:R173.
   Web of Science ®Google Scholar
• Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int. 1991;8(6):485–494.
   PubMed Web of Science ®Google Scholar
• Shiga T, Fujimura A, Tateishi T, Ohashi K, Ebihara A. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects. J Clin Pharmacol. 1993;33(8):756–761.
   Web of Science ®Google Scholar
• Koopmans R, Oosterhuis B, Karemaker JM, Wemer J, van Boxtel CJ. The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. Eur J Clin Pharmacol. 1993;44:171–176.
   PubMed Web of Science ®Google Scholar
• Langner B, Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol. 1988;33:619–624.
   PubMed Web of Science ®Google Scholar
• Semenowicz-Siuda K, Markiewicz A, Korczynska-Wardecka J. Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis. Int J Clin Pharmacol Ther Toxicol. 1984;22:653–658.
   PubMedGoogle Scholar
• Jespersen CM, Frederiksen M, Hansen JF, Klitgaard NA, Sorum C. Circadian variation in the pharmacokinetics of verapamil. Eur J Clin Pharmacol. 1989;37(6):613–615.
   Web of Science ®Google Scholar
• Hla KK, Latham AN, Henry JA. Influence of time of administration on verapamil pharmacokinetics. Clin Pharmacol Ther. 1992;51(4):366–370.
   Web of Science ®Google Scholar
• Lemmer B. Circadian Rhythms in the Cardiovascular System. London, UK: Butterworth; 1989:51–70.
   Google Scholar
• Lemmer B. Chronopharmacology of hypertension. Ann NY Acad Sci. 1996;783:242–253.
   PubMed Web of Science ®Google Scholar
• Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from chronobiological point of view. Blood Press Monit. 1996;1:161–169.
   PubMedGoogle Scholar
• Lemmer B. . Cardiovascular chronobiology and chronopharmacology: importance of timing of dosing. In: White WB, editor. Cardiovascular Chronobiology and Variability in Clinical Research and Clinical Practice. Totowa, NJ: Humana Press; 2001:255–272.
   Google Scholar
• Lemmer B. Chronopharmakologie, 4th ed. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft; 2012.
   Google Scholar
• Lemmer B. . Chronobiology and chronopharmacology of hypertension: importance of timing of dosing. In: White WB, editor. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. 2nd ed. Totowa, NJ: Humana Press; 2007.
   Google Scholar
• Deutsche Hochdruckliga. Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie. Heidelberg, Germany: Deutsche Hochdruckliga; 2003.
   Google Scholar
• Lemmer B. . Chronobiology and chronopharmacology of hypertension. In: White WB, editor. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. 2nd ed. Totowa, NJ: Humana Press; 2007:413–435.
   Google Scholar
• Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007;59(9–10):923–939.
   PubMed Web of Science ®Google Scholar
• Raftery EB, Millar-Craig MW, Mann S, Balasubramanian V Effects of treatment on circadian rhythms of blood pressure. Biotelem Patient Monit. 1981;8:113–120.
   PubMedGoogle Scholar
• Deutsche Hochdruckliga. Leitlinien zur Behandlung der arteriellen Hypertonie. 2008. Available from: http://www.awmf.org/uploads/tx_szleitlinien/046–001_S2_Behandlung_der_arteriellen_Hyper- tonie_06–2008_06–2013.pdf. Accessed March 1, 2012.
   Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky MH, Portaluppi F. Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation. Expert Rev Cardiovasc Ther. 2007;5(3):463–475.
   PubMedGoogle Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–180.
   PubMed Web of Science ®Google Scholar
• Cruickshank JM. The place of beta-blockers in cardiovascular medicine. Cardiologia. 1995;40(11):829–843.
   PubMedGoogle Scholar
• Eguchi K, Kario K, Shimada K. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. Am J Cardiol. 2003;92(5):621–624.
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugellini A, Zoppi A, et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens. 2003;16(7):596–599.
   Web of Science ®Google Scholar
• Frishman WH. New therapeutic modalities in hypertension: focus on a new calcium antagonist – nicardipine. J Clin Pharmacol. 1989;29:481–487.
   Web of Science ®Google Scholar
• Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999;353(9153):611–616.
   PubMed Web of Science ®Google Scholar
• Lacourciere Y, Neutel JM, Davidai G, Koval S. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Am J Hypertens. 2006;19(1):104–112.
   Web of Science ®Google Scholar
• Mancia G, Seravalle G, Grassi G. Tolerability and treatment compliance with angiotensin II receptor antagonists. Am J Hypertens. 2003;16(12):1066–1073.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA. 1998;279(23):1903–1907.
   PubMed Web of Science ®Google Scholar
• Reid JL. New therapeutic agents for hypertension. Br J Clin Pharmacol. 1996;42(1):37–41.
   Web of Science ®Google Scholar
• van Zwieten PA. Development and trends in the drug treatment of essential hypertension. J Hypertens. 1992;10:S1–S12.
   Web of Science ®Google Scholar
• Weber MA, Laragh JH. Hypertension – steps forward and steps backward – the Joint National Committee Fifth Report. Arch Intern Med. 1993;153(2):149–152.
   Google Scholar
• White WB. Update on the drug treatment of hypertension in patients with cardiovascular disease. Am J Med. 2005;118(7):695–705.
   Web of Science ®Google Scholar
• Zanchetti A, Chalmers JP, Gyafras I, Hansson L, Mancia G, Strasser T. 1991 Guidelines for the Prevention of Hypertension and Associated Cardiovascular Disease – Joint World Health Organiza- tion/ International Society of Hypertension Meeting. J Hypertens. 1992;10(1):97–99.
   Web of Science ®Google Scholar
• Chobanian M, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• White WB. The usefulness of ambulatory blood pressure monitoring to assess antihypertensive therapy. Blood Press Monit. 1996;1:149–150.
   Google Scholar
• White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. Am J Med. 2008;121(8 Suppl):S2–S7.
   Web of Science ®Google Scholar
• Middeke M. Ambulatory long-term blood pressure measurement. MMWFortschrMed. 2006;148(37):37–38, 40, 42.
   Google Scholar
• Mancia G, Parati G. Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring. Curr Hypertens Rep. 2006;8(4):330–337.
   Web of Science ®Google Scholar
• Schrader J, Luders S, Zuchner C, Herbold M, Schrandt G. Practice vs ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): a randomised, prospective long-term study to evaluate the benefits of ABPM in patients on antihypertensive treatment. J Hum Hypertens. 2000;14(7):435–440.
   Web of Science ®Google Scholar
• Stanton A, O’Brien E. Auswirkungen der Therapie auf das zirkadiane Blutdruckprofil. Kardio (Pfizer). 1994;3:1–14.
   Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–180.
   PubMed Web of Science ®Google Scholar
• Lemmer B. Circadiane Rhythmen und klinische Pharmakologie. Internist. 2004;45:1006–1020.
   PubMedGoogle Scholar
• Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int. 1991;8(6):485–494.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Nold G, Kaiser R. Sustained-release nifedipine in hypertensives: 24-h-monitoring of blood pressure, heart rate, pharmacokinetics and cAMP. Naunyn Schmiedebergs Arch Pharmacol. 1991;343 Suppl:R125.
   Google Scholar
• Mengden T, Binswanger B, Gruene S, Spühler T, Weisser B, Vetter W. Dynamics of drug compliance and 24-hour blood pressure control of once daily morning vs evening amlodipine. J Hypertens. 1992; 10 Suppl 4:S136.
   Google Scholar
• Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17–25.
   PubMedGoogle Scholar
• Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24-h ambulatory monitoring. Br J Clin Pharmacol. 1993;35(1):51–54.
   Web of Science ®Google Scholar
• Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Investig. 1994;72(11):864–869.
   Google Scholar
• White WB, Mansoor GA, Pickering TG, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12(8 Pt 1):806–814.
   PubMed Web of Science ®Google Scholar
• Meilhac B, Mallion JM, Carre A, et al. Antihypertensive effect and tolerance of nitrendipine administered either in the morning or in the evening of office and ambulatory blood pressure. Therapie. 1992;47(3):205–210.
   Web of Science ®Google Scholar
• Umeda T, Naomi S, Iwaoka T, et al. Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension. 1994;23 Suppl 1:I211–I214.
   Google Scholar
• van Montfrans GA, Schelling A, Buurke EJ, Schut N, Houben JJ. Dosing time of lacidipine and the circadian blood pressure curve: the MOTIME study. J Hypertens. 1998;16 Suppl 9:S15–S19.
   Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension of chronic renal failure. Am J Hypertens. 1995;8(7):719–726.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Luders S, Schrader J, et al. Chronopharmacology of amlodipine in non-dippers and dippers. Naunyn Schmiedebergs Arch Pharmacol. 2003;367 Suppl 1:R113.
   Google Scholar
• Lemmer B, Luders S, Nold G, Schrader J, Manfredini R, Portaluppi F. Normalisation of non-dipping blood pressure profile by amlodipine after single morning or evening dosing. Am J Hypertens. 2002;15:109A.
   Google Scholar
• Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-hour blood pressure control with ramipril: Comparison of once-daily morning and evening administration. Curr Ther Res Clin Exp. 1995;56:1298–1306.
   Web of Science ®Google Scholar
• Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52:378–383.
   PubMed Web of Science ®Google Scholar
• Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, Lemmer B. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 199354:177–186.
   Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–1922.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol Int. 2007;24(1):171–181.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Yamanaka T, Mizuno M, et al. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008;26(3):583–588.
   Web of Science ®Google Scholar
• Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens. 2004;26(2):177–189.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42(3):283–290.
   Web of Science ®Google Scholar
• Pechere-Bertschi A, Nussberger J, Decosterd L, et al. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens. 1998;16:385–393.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007;50(4):715–722.
   Web of Science ®Google Scholar
• Raftery EB, Melville DI, Gould BA, Mann S, Whittington JR. A study of the antihypertensive action of xipamide using ambulatory intra- arterial monitoring. Br J Clin Pharmacol. 1981;12:381–385.
   PubMed Web of Science ®Google Scholar
• Ocon J, Mora J. Twenty-four-hour blood pressure monitoring and effects of indapamide. Am J Cardiol. 1990;65 Suppl H:58H-61H.
   Web of Science ®Google Scholar
• Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100(15):1635–1638.
   PubMed Web of Science ®Google Scholar